NCT01366378View on ClinicalTrials.gov

Effect of Cimetidine on the Single-Dose PK of IV- Administered MNTX

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Healthy Adult Subjects
Interventions
DRUG

methylnaltrexone

Trial Locations (1)

10591

Progenics Pharmaceuticals, Inc., Tarrytown

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT01366378 - Effect of Cimetidine on the Single-Dose PK of IV- Administered MNTX | Biotech Hunter | Biotech Hunter